E. Ben Hamida Nouaïli
S. Chaouachi
N. Meftah
Rafika Bardi
Rachida Sfar
Zohra Marrakchi


Background : While toxoplasmosis infection in women is often benign, transmission of maternal infection to the fetus can lead to severe sequelae. Because the majority of patients with acute toxoplasmosis are asymptomayic, a systematic serologic screening program will needed with monthly serologic screening of all seronegative pregnant women until delivery. The aim of this study was to identify cases of congenital toxoplasmosis among all live births of women found to be seronegative in pregnancy once at least.
Methods : During a prospective study period of 16 months (from 07/02/2003 to 30/06/2004) we conduct a neonatal screening of all live births of women found to be seronegative in pregnancy once at least. Peripheral samples were obtained from every couple mother/ infant. Serological methods performed for diagnosis of toxoplasma specific IgM and IgG antibodies were Hemaglutination and Enzymelinked immunosorbent assay (ELISA).
Results: Four cases of congenital toxoplasmosis were diagnosed after birth. All cases were asymptomatic and a specific treatment was started soon after diagnosis. The clinical and serologic evolution was normal in three cases. A serologic rebound at two years was reported in one case with a chorioretinitis in the examination of the ocular fundus.
Conclusion: Neonatal as well maternal screening during pregnancy and at birth should be systematic to prevent, diagnose and treat early the affected neonates usually asymptomatic.


Congenital toxoplasmosis, , serodiagnosis, screening, prevention



  1. Freij BJ, Sever JL. Toxoplasmosis. Pediatr Rev 1991 ;12 :227.
  2. Guerina NG, Hsu H-W, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital toxoplasma gondii infection. N Engl J Med 1994;330:1858.
  3. Bouratbine A, Siala E, Chahed MK, Aoun K, Ben Ismail R. Seroepidemiologic profile of toxoplasmosis in northern Tunisia. Parasite. 2001 ;8:61-6.
  4. Cook AJ, Gilbert RE. Buffolano W et al. Sources of toxoplasma infection in pregnant women: European multicentre case control study. European Research Network on Congenital. Toxoplasmosis. Br Med J 2000; 321:142-7.
  5. Conyn-van Spaedonck MA, van Knapen F. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Scand J Infect Dis 1991; 84:51-8.
  6. Couvreur J. Le problème de la toxoplasmose congénitale. L'évolution sur quatre décennies. Presse Med 1999; 28:753-7.
  7. Remington JS, McLeod R, Thulliez P, et al. Toxoplasmosis. In :Remington JS,Klein JO, eds. Infectious diseases of the fetus and newborn infant, 5th ed. Philadelphia: WB Saunders, 2001:205.
  8. McAuley J, Boyer KM, Patel D, Mets M et al. Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994; 18:38-72
  9. Peyron F., Ateba A.B, Wallon M. et al. - Congenital toxoplasmosis in twins: a report of fourteen consecutive cases and comparison with published data. Pediat. infect. Dis. J. 2003;22: 695-70.
  10. Fortier B, Coignard-Chatain C, Dao A et al. Etude des poussées cliniques évolutives et des rebonds sérologiques d'enfants atteints de toxoplasmose congénitale et suivis durant les deux premières années de vie. Arch Pédiatr 1997 ;4 :940-946.
  11. Chumpitazi BFF, Boussaid A, Pelloux H, et al. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods J Clin Microbiol 1995.; 33:1479.
  12. Tissot Dupont D, Fricker-Hidalgo H, Brenier-Pinchart MP, et al. Usefulness of western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:122.